Possible New Treatment for CF and NTM
Trial Objectives
Researchers in the ABATE Study are testing the safety of a drug called gallium nitrate for people with cystic fibrosis (CF) who also have been diagnosed with nontuberculous mycobacteria (NTM). Gallium nitrate is currently FDA-approved to treat high calcium in blood caused by cancer. Its use in treating people with CF is experimental, but gallium nitrate is thought to have antimicrobial properties that would help resolve NTM infections.